Hydreight Technologies Inc ( (TSE:NURS) ) just unveiled an announcement.
Hydreight Technologies Inc. has been recognized as one of the fastest-growing companies in the Americas by the Financial Times, highlighting its significant revenue growth from $400K to nearly $24M between 2020 and 2023. This accolade underscores the company’s robust performance and its strategic positioning in the direct-to-consumer telehealth market. Hydreight plans to expand its offerings and national footprint in 2025, further enhancing its value proposition for investors and stakeholders. The recognition reflects the increasing demand for accessible and scalable healthcare solutions, reinforcing Hydreight’s commitment to patient-centered services across the U.S.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. is a digital health platform that operates one of the largest mobile clinic networks in the United States. It provides a proprietary platform that integrates tools for accounting, documentation, sales, inventory, booking, and patient data management, enabling healthcare professionals to deliver services directly to patients. The company is involved in high-growth sectors such as GLP-1 weight-loss medications, anti-aging therapies, IV wellness, at-home testing, and chronic care management. Hydreight is affiliated with a U.S. certified e-script and telemedicine provider network.
YTD Price Performance: -47.73%
Average Trading Volume: 98,962
Technical Sentiment Signal: Sell
Current Market Cap: C$27.57M
Find detailed analytics on NURS stock on TipRanks’ Stock Analysis page.